Long-term clinical outcome of primary progressive MS: predictive value of clinical and MRI data

J Sastre-Garriga1, G T Ingle, M Rovaris

  • 1Institute of Neurology, UCL, Queen Square, London WC1N 3BG, UK.

Neurology
|August 24, 2005
PubMed

Insights

Predicting outcomes in primary progressive multiple sclerosis (PPMS) is crucial. Clinical and MRI data at baseline and over time help forecast long-term disease progression in PPMS patients.

Area of Science:

  • Neurology
  • Neuroimaging
  • Clinical Research

Background:

  • Primary progressive multiple sclerosis (PPMS) is a debilitating neurological condition.
  • Identifying predictors of disease progression is essential for patient management.
  • Current understanding of PPMS outcome predictors requires further elucidation.

Purpose of the Study:

  • To identify clinical and magnetic resonance imaging (MRI) predictors of long-term outcome in PPMS.
  • To evaluate the predictive value of baseline and short-term changes in clinical and MRI metrics.
  • To establish robust prognostic indicators for PPMS patients.

Main Methods:

  • Longitudinal study design involving clinical and MRI assessments.
  • Baseline assessments included disease duration, Expanded Disability Status Scale (EDSS), and brain volume.
  • Follow-up assessments at 2 and 5 years (clinical only) captured disease changes.

Main Results:

  • Baseline predictors of outcome included disease duration, EDSS, and brain volume.
  • Short-term changes, including baseline EDSS, T2* lesion load, cord area, and new lesion counts, were also predictive.
  • A combination of clinical and MRI variables effectively predicted long-term outcomes.

Conclusions:

  • Clinical and MRI variables are significant predictors of long-term outcomes in PPMS.
  • Integrating baseline and change metrics enhances prognostic accuracy.
  • These findings can inform clinical trial design and patient care strategies for PPMS.